Skip to main content
Clinical Trials/NCT07666763
NCT07666763Not yet recruitingNot Applicable

Influence of Acetal Resin Versus Nylon Elastic Cap on Crestal Bone Loss in Mandibular Implant-Supported Overdenture

Future University in Egypt0 sites22 target enrollmentStarted: July 1, 2026Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
22

Study Overview

Brief Summary

Objective: To evaluate and compare the effect of two different attachment housing materials-Acetal Resin (Polyoxymethylene) versus conventional Nylon elastic caps-on marginal crestal bone loss around dental implants supporting a mandibular overdenture. It also evaluates peri-implant clinical tissue health by measuring pocket depth and the gingival bleeding index.

Detailed Description

Study Design & Timeline: A prospective, double-blind, randomized controlled clinical trial with a 1:1 allocation ratio. Clinical and radiographic outcomes will be evaluated at overdenture insertion (baseline), and at 6 and 12 months post-insertion.ethodology & Analysis: Pre-operative bone volume will be assessed via Cone Beam CT (CBCT). Crestal bone loss will be measured using the long cone parallel radiographic technique , while pocket depth and gingival bleeding will be measured using a William's graduated probing device. Data will undergo normality testing to determine the use of parametric (Independent t-test, Repeated Measures ANOVA) or non-parametric (Mann-Whitney, Friedman) statistical analyse

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Triple (Participant, Care Provider, Outcomes Assessor)

Eligibility Criteria

Ages
40 Years to 60 Years (Adult)
Sex
Male
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Completely edentulous mandible.
  • Sufficient bone height/width in mandibular residual ridges.
  • Angles classification class I.
  • Sufficient inter-arch distance

Exclusion Criteria

  • TMJ disorders.
  • Hypertensive
  • Cancer patients.
  • Osteoporosis.
  • Immunosuppressive disease
  • Any disease affecting bone/implant stability.

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Seif eldin Diaa Ezzat

Postgrad stuident

Future University in Egypt

Similar Trials